Tumor-infiltrating Foxp3+ regulatory T cells are correlated with cyclooxygenase-2 expression and are associated with recurrence in resected non-small cell lung cancer.

PubWeight™: 1.73‹?› | Rank: Top 3%

🔗 View Article (PMID 20234320)

Published in J Thorac Oncol on May 01, 2010


Katsuhiko Shimizu1, Masao Nakata, Yuji Hirami, Takuro Yukawa, Ai Maeda, Kazuo Tanemoto

Author Affiliations

1: Division of Thoracic and Cardiovascular Surgery, Department of Surgery, Kawasaki Medical School, Kurashiki, Japan. kshimizu@med.kawasaki-m.ac.jp

Articles citing this

The immune contexture in human tumours: impact on clinical outcome. Nat Rev Cancer (2012) 10.90

The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis. Br J Cancer (2011) 3.45

Trial watch: Prognostic and predictive value of the immune infiltrate in cancer. Oncoimmunology (2012) 1.78

Biomarkers in early-stage non-small-cell lung cancer: current concepts and future directions. J Thorac Oncol (2014) 1.56

Clinical impact of immune microenvironment in stage I lung adenocarcinoma: tumor interleukin-12 receptor β2 (IL-12Rβ2), IL-7R, and stromal FoxP3/CD3 ratio are independent predictors of recurrence. J Clin Oncol (2012) 1.50

KRAS mutations are associated with solid growth pattern and tumor-infiltrating leukocytes in lung adenocarcinoma. Mod Pathol (2013) 1.16

The role of complement in tumor growth. Adv Exp Med Biol (2014) 1.11

Toward integrative cancer immunotherapy: targeting the tumor microenvironment. J Transl Med (2012) 1.04

Prognostic Effect of Tumor Lymphocytic Infiltration in Resectable Non-Small-Cell Lung Cancer. J Clin Oncol (2016) 0.99

Detection and significance of TregFoxP3(+) and Th17 cells in peripheral blood of non-small cell lung cancer patients. Arch Med Sci (2014) 0.95

Clinical significance of the tumor microenvironment in non-small cell lung cancer. Ann Transl Med (2013) 0.92

Tumor microenvironment in NSCLC suppresses NK cells function. Oncoimmunology (2012) 0.91

Clinical evaluation of systemic and local immune responses in cancer: time for integration. Cancer Immunol Immunother (2013) 0.89

Predictive factors of activity of anti-programmed death-1/programmed death ligand-1 drugs: immunohistochemistry analysis. Transl Lung Cancer Res (2015) 0.88

Non-Small-Cell Lung Cancer: Role of the Immune System and Potential for Immunotherapy. J Thorac Oncol (2015) 0.87

Adaptive immunity in cancer immunology and therapeutics. Ecancermedicalscience (2014) 0.87

Adenocarcinoma contains more immune tolerance regulatory t-cell lymphocytes (versus squamous carcinoma) in non-small-cell lung cancer. Lung (2013) 0.86

Prognostic and predictive value of tumor-infiltrating lymphocytes for clinical therapeutic research in patients with non-small cell lung cancer. Oncotarget (2016) 0.86

Targeting PD-1/PD-L1 in lung cancer: current perspectives. Lung Cancer (Auckl) (2015) 0.86

Enhanced frequency and potential mechanism of B regulatory cells in patients with lung cancer. J Transl Med (2014) 0.85

Linear quantification of lymphoid infiltration of the tumor margin: a reproducible method, developed with colorectal cancer tissues, for assessing a highly variable prognostic factor. Diagn Pathol (2012) 0.84

Tumors as organs: biologically augmenting radiation therapy by inhibiting transforming growth factor β activity in carcinomas. Semin Radiat Oncol (2013) 0.83

Identification of prognostic immunophenotypic features in cancer stromal cells of high-grade neuroendocrine carcinomas of the lung. J Cancer Res Clin Oncol (2013) 0.83

The Treg/Th17 paradigm in lung cancer. J Immunol Res (2014) 0.82

What lies within: novel strategies in immunotherapy for non-small cell lung cancer. Oncologist (2013) 0.81

IRX-2, a novel biologic, favors the expansion of T effector over T regulatory cells in a human tumor microenvironment model. J Mol Med (Berl) (2011) 0.81

Evolving Concepts: Immunity in Oncology from Targets to Treatments. J Oncol (2015) 0.81

Progressive Increase of Regulatory T Cells and Decrease of CD8+ T Cells and CD8+ T Cells/Regulatory T Cells Ratio during Colorectal Cancer Development. Korean J Pathol (2013) 0.81

Disturbed Th17/Treg Balance in Patients with Non-small Cell Lung Cancer. Inflammation (2015) 0.80

Cellular and molecular immunology of lung cancer: therapeutic implications. Expert Rev Clin Immunol (2014) 0.79

Tumor infiltrating lymphocytes in lung cancer: a new prognostic parameter. J Thorac Dis (2016) 0.78

Prognostic value of circulating regulatory T cell subsets in untreated non-small cell lung cancer patients. Sci Rep (2016) 0.77

Emerging roles of T helper 17 and regulatory T cells in lung cancer progression and metastasis. Mol Cancer (2016) 0.77

Therapeutic cancer vaccines in prostate cancer: the quest for intermediate markers of response. Cancers (Basel) (2012) 0.77

Analysis of the immune microenvironment in resected non-small cell lung cancer: the prognostic value of different T lymphocyte markers. Oncotarget (2016) 0.76

Clinicopathological and prognostic significance of regulatory T cells in patients with non-small cell lung cancer: A systematic review with meta-analysis. Oncotarget (2016) 0.76

Tumor-infiltrating immune cell subpopulations influence the oncologic outcome after intravesical Bacillus Calmette-Guérin therapy in bladder cancer. Oncotarget (2016) 0.76

Intrapulmonary Delivery of CpG Microparticles Eliminates Lung Tumors. Mol Cancer Ther (2015) 0.76

The tumor immune microenvironment in octogenarians with stage I non-small cell lung cancer. Oncoimmunology (2014) 0.76

Dexamethasone co-medication in cancer patients undergoing chemotherapy causes substantial immunomodulatory effects with implications for chemo-immunotherapy strategies. Oncoimmunology (2015) 0.75

In reply: Tumor-associated lymphocytes expanded ex vivo from malignant ascites. J Gynecol Oncol (2010) 0.75

Micro RNA-98 interferes with expression interleukin-10 in peripheral B cells of patients with lung cancer. Sci Rep (2016) 0.75

Expression of tumoral FOXP3 in gastric adenocarcinoma is associated with favorable clinicopathological variables and related with Hippo pathway. Int J Clin Exp Pathol (2015) 0.75

Targeted immunotherapy for non-small cell lung cancer. World J Clin Oncol (2014) 0.75

Tumour-infiltrating regulatory T cell density before neoadjuvant chemoradiotherapy for rectal cancer does not predict treatment response. Oncotarget (2017) 0.75

Urinary levels of prostaglandin E2 are positively correlated with intratumoral infiltration of Foxp3(+) regulatory T cells in non-small cell lung cancer. Oncol Lett (2017) 0.75

Human lung tumor FOXP+ Tregs upregulate four "Treg-locking" transcription factors. JCI Insight (2017) 0.75

Articles by these authors

Thoracic and cardiovascular surgery in Japan during 2012 : annual report by The Japanese Association for Thoracic Surgery. Gen Thorac Cardiovasc Surg (2014) 1.65

Current venous thromboembolism management and outcomes in Japan. Circ J (2014) 1.62

Inflammatory pseudotumor of the lung: clinicopathological analysis in seven adult patients. Int J Clin Oncol (2006) 1.55

Inhibitory effects of NFkappaB decoy oligodeoxynucleotides on neointimal hyperplasia in a rabbit vein graft model. J Mol Cell Cardiol (2006) 1.52

Maximal standardized uptake value on FDG-PET is correlated with cyclooxygenase-2 expression in patients with lung adenocarcinoma. Ann Thorac Surg (2011) 1.46

Preoperative chronic kidney disease as a strong predictor of postoperative infection and mortality after coronary artery bypass grafting. Circ J (2014) 1.43

Multiple ground-glass opacity in metastasis of malignant melanoma diagnosed by lung biopsy. Ann Thorac Surg (2005) 1.41

A granulomatous liver abscess which developed after a toothpick penetrated the gastrointestinal tract: report of a case. Surg Today (2003) 1.22

Analysis of reactive oxygen metabolites (ROMs) after cardiovascular surgery as a marker of oxidative stress. Acta Med Okayama (2010) 1.20

Long-term prognosis of patients with type a aortic intramural hematoma. Circulation (2002) 1.19

Surgical treatments for multiple primary adenocarcinoma of the lung. Ann Thorac Surg (2004) 1.18

Objective radiologic analysis of ground-glass opacity aimed at curative limited resection for small peripheral non-small cell lung cancer. J Thorac Cardiovasc Surg (2005) 1.12

Expression of eukaryotic initiation factor 4E in atypical adenomatous hyperplasia and adenocarcinoma of the human peripheral lung. Clin Cancer Res (2002) 1.10

Two cases of acute bioprosthetic mitral valve thrombosis immediately after mitral valve replacement. Circulation (2014) 1.06

Post-recurrence survival of patients with non-small-cell lung cancer after curative resection with or without induction/adjuvant chemotherapy. Interact Cardiovasc Thorac Surg (2012) 1.05

Mutation of the epidermal growth factor receptor gene in the development of adenocarcinoma of the lung. Lung Cancer (2007) 0.96

Clinicopathological analysis of multifocal micronodular pneumocyte hyperplasia associated with tuberous sclerosis in Japan. Respirology (2008) 0.93

Prognostic significance of expression of eukaryotic initiation factor 4E and 4E binding protein 1 in patients with pathological stage I invasive lung adenocarcinoma. Lung Cancer (2010) 0.92

Heterogeneity of the EGFR mutation status between the primary tumor and metastatic lymph node and the sensitivity to EGFR tyrosine kinase inhibitor in non-small cell lung cancer. Target Oncol (2012) 0.92

Multifocal micronodular pneumocyte hyperplasia associated with tuberous sclerosis: differentiation from multiple atypical adenomatous hyperplasia. Jpn J Clin Oncol (2008) 0.91

Unknown primary large cell neuroendocrine carcinoma (LCNEC) in the mediastinum. Gen Thorac Cardiovasc Surg (2012) 0.88

Evaluation of video-assisted thoracoscopic surgery for pulmonary metastases: 11-years of experience. Surg Endosc (2008) 0.87

Calcified amorphous tumor: three-dimensional transesophageal echocardiography. Asian Cardiovasc Thorac Ann (2012) 0.87

Length of stay and cost for surgical site infection after abdominal and cardiac surgery in Japanese hospitals: multi-center surveillance. Surg Infect (Larchmt) (2012) 0.86

Advanced age is not correlated with either short-term or long-term postoperative results in lung cancer patients in good clinical condition. Chest (2005) 0.85

Recent results regarding the clinical impact of smoking history on postoperative complications in lung cancer patients. Interact Cardiovasc Thorac Surg (2008) 0.85

Teratoma with malignant transformation in the anterior mediastinum. J Thorac Cardiovasc Surg (2008) 0.84

Measurement of localized ground-glass attenuation on thin-section computed tomography images: correlation with the progression of bronchioloalveolar carcinoma of the lung. Invest Radiol (2002) 0.84

Prognosis of retrograde dissection from the descending to the ascending aorta. Circulation (2003) 0.83

Long-term prognosis of patients with type B aortic intramural hematoma. Circulation (2003) 0.83

Membrane-bound estrogen receptor-α expression and epidermal growth factor receptor mutation are associated with a poor prognosis in lung adenocarcinoma patients. World J Surg Oncol (2012) 0.83

Identification of CCDC62-2 as a novel cancer/testis antigen and its immunogenicity. Int J Cancer (2009) 0.83

Influence of vascular endothelial growth factor single nucleotide polymorphisms on non-small cell lung cancer tumor angiogenesis. Oncol Rep (2012) 0.82

Solitary pulmonary nodule due to Mycobacterium kansasii. Intern Med (2011) 0.81

Total aortic arch replacement for a patient with poor left ventricular function and patent coronary artery bypass grafts: how to establish effective myocardial protection. Gen Thorac Cardiovasc Surg (2011) 0.81

Collective therapy and therapeutic strategy for critical limb ischemia. Ann Vasc Dis (2013) 0.81

Current topics on bicuspid aortic valve: clinical aspects and surgical management. Ann Thorac Cardiovasc Surg (2015) 0.80

Early outcomes of chordal reconstruction for posterior mitral leaflet prolapse. Asian Cardiovasc Thorac Ann (2012) 0.80

Traumatic rupture of a right aortic arch in a patient with an aberrant left subclavian artery. J Thorac Cardiovasc Surg (2006) 0.80

Lung cancer with localized ground-glass attenuation represents early-stage adenocarcinoma in nonsmokers. J Thorac Oncol (2008) 0.80

Cosmetic approach for correction of simple congenital heart defects in female patients. Jpn J Thorac Cardiovasc Surg (2004) 0.80

[A case of pulmonary Mycobacterium intracellulare infectious disease with a solitary pulmonary nodule in the peripheral lung field]. Nihon Kokyuki Gakkai Zasshi (2004) 0.79

Unsuspected primary pulmonary malignant lymphoma. Jpn J Thorac Cardiovasc Surg (2002) 0.79

Coexistence of metastatic lung cancer and pulmonary tuberculosis diagnosed in the same cavity. Int J Clin Oncol (2005) 0.79

Mucosa-associated lymphoid tissue lymphoma in the thymus of a patient with systemic lupus erythematosus. Gen Thorac Cardiovasc Surg (2008) 0.79

[Pulmonary resection for metastatic colorectal cancer]. Gan To Kagaku Ryoho (2002) 0.78

Difference in prognostic values of maximal standardized uptake value on fluorodeoxyglucose-positron emission tomography and cyclooxygenase-2 expression between lung adenocarcinoma and squamous cell carcinoma. World J Surg Oncol (2014) 0.78

Impact of diabetes mellitus on outcomes in Japanese patients undergoing coronary artery bypass grafting. J Cardiol (2012) 0.78

Current status and future perspectives of prosthetic valve selection for aortic valve replacement. Gen Thorac Cardiovasc Surg (2013) 0.78

Influence of prosthetic heart valve sound on a patient's quality of life. Ann Thorac Cardiovasc Surg (2010) 0.78

Changes of asymmetric dimethylarginine, nitric oxide, tetrahydrobiopterin, and oxidative stress in patients with acute myocardial infarction by medical treatments. Clin Hemorheol Microcirc (2007) 0.78

Impact of energy loss coefficient on left ventricular mass regression in patients undergoing aortic valve replacement: preliminary observation. J Am Soc Echocardiogr (2009) 0.78

Current status of postoperative follow-up for lung cancer in Japan: questionnaire survey by the Setouchi Lung Cancer Study Group-A0901. Gen Thorac Cardiovasc Surg (2012) 0.77

Frailty in cardiothoracic surgery: systematic review of the literature. Gen Thorac Cardiovasc Surg (2015) 0.76

Preoperative oral administration of pentoxifylline ameliorates respiratory index after cardiopulmonary bypass through decreased production of IL-6. Acta Med Okayama (2008) 0.76

A case report of intrapulmonary schwannoma. Gen Thorac Cardiovasc Surg (2013) 0.75

Evaluation of conservative therapy for intermittent claudication. Circ J (2012) 0.75

Restrictive mitral annuloplasty for functional mitral regurgitation in patients with end-stage cardiomyopathy. Circ J (2011) 0.75

Histological comparison between preoperative and surgical specimens of non-small cell lung cancer for distinguishing between "squamous" and "non-squamous" cell carcinoma. Diagn Pathol (2014) 0.75

Lapatinib enhances trastuzumab-mediated antibody-dependent cellular cytotoxicity via upregulation of HER2 in malignant mesothelioma cells. Oncol Rep (2015) 0.75

Two-stage Surgery for Double Infected Aneurysms in the Infrarenal Abdominal and Descending Thoracic Aorta. Ann Vasc Dis (2011) 0.75

Clopidogrel for Atherothrombotic Event Management in Patients with Peripheral Arterial Disease (COOPER) Study: Safety and Efficacy of Clopidogrel versus Ticlopidine in Japanese Patients. Ann Vasc Dis (2012) 0.75

Role of 2-[18F]fluoro-2-deoxyglucose positron emission tomography in preoperative management of solid-type small-sized lung cancer. Ann Nucl Med (2013) 0.75

Induction chemoradiation therapy with cisplatin plus irinotecan followed by surgical resection for superior sulcus tumor. Ann Thorac Cardiovasc Surg (2010) 0.75

Serial 3-dimensional volumetric computed tomography evaluation of lung cancer growth rate in patients with chronic obstructive pulmonary disease findings. J Comput Assist Tomogr (2012) 0.75

Pulmonary apical mass, the so-called pulmonary apical cap, in a 43-year-old woman. Ann Thorac Cardiovasc Surg (2010) 0.75

Pseudoaneurysm at the aortic anastomosis following heart transplantation. J Card Surg (2011) 0.75